After the failure of citalopram for depression, what next?

Expert Opinion on Pharmacotherapy

Volumn 7, Issue 11, 2006, Pages 1515-1518

  Doggrell, Sheila A ^a  

^a CHARLES DARWIN UNIVERSITY   (Australia)

Author keywords

Bupropion; Buspirone; Citalopram; Extended release venlafaxine; Major depression; Selective serotonin re uptake inhibitor; Sertaline; SSRI; Sustained release bupropion; Venlafaxine

Indexed keywords

AMFEBUTAMONE; BUSPIRONE; CITALOPRAM; FLUOXETINE; PLACEBO; SERTRALINE; VENLAFAXINE;

ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG METABOLISM; DRUG PREFERENCE; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TOLERANCE; DRUG WITHDRAWAL; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MEDICAL DECISION MAKING; REMISSION; SUSTAINED DRUG RELEASE; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT;

CITALOPRAM; DEPRESSIVE DISORDER; HUMANS; PLACEBOS; REMISSION INDUCTION; TREATMENT FAILURE; UNCERTAINTY;

EID: 33746850501     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.7.11.1515     Document Type: Article

References (8)

1. REIMHERR FW, CUNNINGHAM LA, BATEY SR, JOHNSTON JA, ASCER JA: A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients. Clin. Ther. (1998) 20:505-516.
2. JOFFE RT, SCHULLER DR: An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J. Clin. Psychiatry (1993) 54:269-271.
3. TRIVEDI MH, RUSH AJ, WISNIEWSKI SR et al.: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry (2006) 163:28-40.
4. RUSH AJ, TRIVEDI MH, WISNIEWSKI SR et al.: Bupriopion-SR, sertaline, or venlafaxine-XR after failure of SSRIs for depression. N. Engl. J. Med. (2006) 354:1231-1242.
5. TRIVEDI MH, FAVA M, WISNIEWSKI SR et al.: Medication augmentation after the failure of SSRIs for depression. N. Engl. J. Med. (2006) 354:1243-1252.
6. RUDOLPH RL, FEIGER AD: A double-blind, randomized, placebo-controlled trial of once-daily venlafazine extended release (XR) and fluoxetine for the treatment of depression. J. Affect. Disord. (1999) 56:171-181.
7. FABRE LF, ABUZZAHAB FS, AMIN JL et al.: Sertaline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Boil. Psychiatry (1995) 38:592-602
8. FABRE LF: Buspirone in the management of major depression: a placebo-controlled comparison. J. Clin. Psychiatry (1990) 51(Suppl.):55-61.